Protein variant presents a potential new target for developing effective treatments for Parkinson's disease
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
News Medical on MSN18h
New biomarker could help predict Parkinson’s disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
pna12h
Researchers identify key protein in Parkinson’s disease’s spread
Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...
GlobalData on MSN1d
DMTs are major clinical research focus for Parkinson’s disease, analysis shows
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
Prothena Corporation plc: Prothena Reports Third Quarter 2024 Financial Results and Business Highlights
Net cash used in operating and investing activities was $45.2 million and $102.5 million for the third quarter and first nine months of 2024, respectively; quarter-end cash and restricted cash positio ...
Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value
Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...
New guideline provides treatment recommendations for restless legs syndrome
A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for ...